{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:44:15Z","timestamp":1790127855189,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370325"],"award-info":[{"award-number":["81370325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670325"],"award-info":[{"award-number":["81670325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.lfs.2019.02.035","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T01:57:45Z","timestamp":1550455065000},"page":"249-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model"],"prefix":"10.1016","volume":"221","author":[{"given":"Xuyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7617-3790","authenticated-orcid":false,"given":"Fengshuang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.02.035_bb0005","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2337\/diacare.26.10.2949","article-title":"Diabetic cardiomyopathy","volume":"26","author":"Bell","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2019.02.035_bb0010","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.lfs.2019.02.035_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential","volume":"172","author":"Faria","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2019.02.035_bb0020","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1089\/ars.2015.6311","article-title":"Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome","volume":"22","author":"Roul","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2019.02.035_bb0025","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2019.02.035_bb0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell."},{"key":"10.1016\/j.lfs.2019.02.035_bb0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2019.02.035_bb0045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jvs.2013.03.048","article-title":"Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis","volume":"59","author":"Hakimi","year":"2014","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.lfs.2019.02.035_bb0050","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1169841","article-title":"HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA","volume":"323","author":"Roberts","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.lfs.2019.02.035_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.immuni.2016.01.020","article-title":"Caspases connect cell-death signaling to organismal homeostasis","volume":"44","author":"Galluzzi","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.lfs.2019.02.035_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lfs.2019.02.035_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri.2016.147","article-title":"Programmed cell death as a defence against infection","volume":"17","author":"Jorgensen","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2019.02.035_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0085","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0140-6736(14)62225-X","article-title":"Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial","volume":"385","author":"Zannad","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lfs.2019.02.035_bb0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1538\/expanim.63.121","article-title":"Diabetic complications in obese type 2 diabetic rat models","volume":"63","author":"Katsuda","year":"2014","journal-title":"Exp. Anim."},{"key":"10.1016\/j.lfs.2019.02.035_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yjmcc.2017.03.002","article-title":"miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes","volume":"105","author":"Feng","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0100","doi-asserted-by":"crossref","first-page":"35618","DOI":"10.18632\/oncotarget.8343","article-title":"Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.lfs.2019.02.035_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2019.02.035_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41418-018-0106-7","article-title":"Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture","volume":"26","author":"de Vasconcelos","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2019.02.035_bb0115","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1038\/cddiscovery.2017.70","article-title":"Cell death and cell lysis are separable events during pyroptosis","volume":"3","author":"DiPeso","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2019.02.035_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.06.012","article-title":"Constitutive interferon maintains GBP expression required for release of bacterial components upstream of pyroptosis and anti-DNA responses","volume":"24","author":"Liu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2019.02.035_bb0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/j.2040-4603.2017.tb00752.x","article-title":"Pathophysiological fundamentals of diabetic cardiomyopathy","volume":"7","author":"Hu","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0130","doi-asserted-by":"crossref","first-page":"5702103","DOI":"10.1155\/2018\/5702103","article-title":"NLRP3: a novel mediator in cardiovascular disease","volume":"2018","author":"Zhou","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2019.02.035_bb0135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","article-title":"MicroRNA-9 inhibits hyperglycemia induced cardiac pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1","volume":"471","author":"Jeyabal","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.02.035_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2019.02.035_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2018.00114","article-title":"Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications","volume":"9","author":"Sharma","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0150","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1007\/s00018-016-2296-9","article-title":"Absent in melanoma 2 proteins in the development of cancer","volume":"73","author":"Choubey","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.lfs.2019.02.035_bb0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.chom.2010.04.004","article-title":"Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol","volume":"7","author":"Sauer","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2019.02.035_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005871","article-title":"Immune-complexed adenovirus induce AIM2-mediated pyroptosis in human dendritic cells","volume":"12","author":"Eichholz","year":"2016","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.lfs.2019.02.035_bb0165","article-title":"Mechanisms of gasdermin family members in inflammasome signaling and cell death","volume":"12","author":"Feng","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/heartjnl-2017-311448","article-title":"Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting","volume":"104","author":"Wilson","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.lfs.2019.02.035_bb0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1440-1681.12720","article-title":"Effects of miRNAs on myocardial apoptosis by modulating mitochondria related proteins","volume":"44","author":"Zhao","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2015.01.014","article-title":"Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy","volume":"403","author":"Xia","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-016-0383-8","article-title":"Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway","volume":"15","author":"Korkmaz-Icoz","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-016-0460-z","article-title":"N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3\/eNOS signaling in diabetic rats","volume":"15","author":"Su","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0195","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijbiomac.2018.02.009","article-title":"Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia\/reperfusion injury","volume":"112","author":"Guo","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2019.02.035_bb0200","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jcmm.13041","article-title":"BRD7 mediates hyperglycaemia-induced myocardial apoptosis via endoplasmic reticulum stress signalling pathway","volume":"21","author":"Wang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2019.02.035_bb0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2018.03.005","article-title":"AIM2 accelerates the atherosclerotic plaque progressions in ApoE\u2212\/\u2212 mice","volume":"498","author":"Pan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.02.035_bb0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2016.03.058","article-title":"Prolyl hydroxylase 3 overexpression accelerates the progression of atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"473","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519301250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519301250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:21:48Z","timestamp":1758399708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519301250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"alternative-id":["S0024320519301250"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.02.035","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}